SAPAREX Trademark

Trademark Overview

On Thursday, October 31, 2013, a trademark application was filed for SAPAREX with the United States Patent and Trademark Office. The USPTO has given the SAPAREX trademark a serial number of 79142349. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, October 30, 2023. This trademark is owned by Cyclacel Limited. The SAPAREX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and biopharmaceuticals for the treatment of cancer
saparex

General Information

Serial Number79142349
Word MarkSAPAREX
Filing DateThursday, October 31, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, October 30, 2023
Registration Number4582406
Registration DateTuesday, August 12, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and biopharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCyclacel Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameCyclacel Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDundee, Tayside DD1
GB
Party NameCyclacel Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDundee, Tayside DD1
GB

Trademark Events

Event DateEvent Description
Monday, February 17, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 18, 2014ASSIGNED TO EXAMINER
Thursday, February 20, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 20, 2014REFUSAL PROCESSED BY MPU
Saturday, February 22, 2014APPLICATION FILING RECEIPT MAILED
Saturday, February 22, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 14, 2014REFUSAL PROCESSED BY IB
Thursday, March 20, 2014PAPER RECEIVED
Monday, March 31, 2014ASSIGNED TO LIE
Tuesday, April 8, 2014ASSIGNED TO LIE
Wednesday, April 16, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 16, 2014AMENDMENT FROM APPLICANT ENTERED
Wednesday, April 16, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 7, 2014NOTICE OF PUBLICATION
Wednesday, May 7, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 7, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, May 23, 2014NOTIFICATION PROCESSED BY IB
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 12, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, November 12, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, November 27, 2014CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, January 28, 2015FINAL DISPOSITION PROCESSED
Wednesday, January 28, 2015FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 14, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, March 14, 2022INVALIDATION PROCESSED
Wednesday, February 19, 2014NON-FINAL ACTION WRITTEN
Friday, March 30, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 26, 2021CANCELLED SECTION 71
Sunday, May 26, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, May 26, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, April 24, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, March 14, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

saparex cancer treatment biopharmaceuticals preparations pharmaceutical